Literature DB >> 8835512

Heterogeneity of rearranged T cell receptor V alpha and V beta gene transcripts in synovial fluid T cells of HLA-B27 positive reactive arthritis patients.

G M Verjans1, V N Klaren, M Leirisalo-Repo, J H Ringrose, H Repo, A Steinle, C E Van Doornik, T E Feltkamp.   

Abstract

To analyze the T cell receptor (TCR) V-alpha/beta gene usage by synovial fluid (SF) and peripheral blood (PB) T cells of HLA-B27+ reactive arthritis (ReA) patients. The TCR V-alpha/beta gene usage was determined by the polymerase chain reaction on freshly isolated SF and PB mononuclear cells (MNC) of five HLA-B27+ ReA patients. A total of 30 TCR V alpha and 23 V beta (sub)family specific primers in combination with a C alpha or C beta specific primer, respectively, were used. In five patients most of the TCR V alpha and V beta gene segments expressed by PB T cells were also detected in the paired SF samples. Although one patient showed an increased expression of TCR V alpha2 in SF when compared to PB, the SF samples showed a heterogeneous TCR V-gene repertoire similar to PB. Although this study was limited to a small group of patients, the apparent lack of a restricted TCR V-gene repertoire in SF does not support the involvement of a single or limited number of T cell subsets in the disease process of HLA-B27+ ReA patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8835512     DOI: 10.1007/bf03342655

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  29 in total

Review 1.  T cell receptors in murine autoimmune diseases.

Authors:  H Acha-Orbea; L Steinman; H O McDevitt
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Where, when, and how to detect biased expression of disease-relevant V beta genes in rats with experimental autoimmune encephalomyelitis.

Authors:  H Offner; A C Buenafe; M Vainiene; B Celnik; A D Weinberg; D P Gold; G Hashim; A A Vandenbark
Journal:  J Immunol       Date:  1993-07-01       Impact factor: 5.422

3.  Interaction of Staphylococcus aureus toxin "superantigens" with human T cells.

Authors:  Y W Choi; B Kotzin; L Herron; J Callahan; P Marrack; J Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Infiltrating T cells from patients with primary Sjögren's syndrome express restricted or unrestricted T cell receptor V beta regions depending on the stage of the disease.

Authors:  F Legras; T Martin; A M Knapp; J L Pasquali
Journal:  Eur J Immunol       Date:  1994-01       Impact factor: 5.532

5.  Lymphocytes from the site of disease but not blood lymphocytes indicate the cause of arthritis.

Authors:  D K Ford; D da Roza; M Schulzer
Journal:  Ann Rheum Dis       Date:  1985-10       Impact factor: 19.103

6.  Lymphocyte surface marker expression in rheumatic diseases: evidence for prior activation of lymphocytes in vivo.

Authors:  M D Smith; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

7.  Restricted expression of T cell receptor V beta but not V alpha genes in rheumatoid arthritis.

Authors:  A Sottini; L Imberti; R Gorla; R Cattaneo; D Primi
Journal:  Eur J Immunol       Date:  1991-02       Impact factor: 5.532

8.  HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis.

Authors:  E Hermann; D T Yu; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Lancet       Date:  1993-09-11       Impact factor: 79.321

9.  Evidence for the effects of a superantigen in rheumatoid arthritis.

Authors:  X Paliard; S G West; J A Lafferty; J R Clements; J W Kappler; P Marrack; B L Kotzin
Journal:  Science       Date:  1991-07-19       Impact factor: 47.728

10.  Multiclonal synovial T cell response to Yersinia enterocolitica in reactive arthritis: the Yersinia 61-kDa heat-shock protein is not the major target antigen.

Authors:  P Probst; E Hermann; K H Meyer zum Büschenfelde; B Fleischer
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.